Artisan Biopharma

We are creating a cultural revolution in the way new pediatric oncology drugs are brought to market.

Introducing Artisan Biopharma

Artisan Biopharma is a for-profit public benefit corporation owned entirely by the Children’s Cancer Therapy Development Institute (cc-TDI). We are the connection for moving breakthrough research and development at cc-TDI into transformative clinical trials. Our mission is to provide research-driven interventions for the treatment and prevention of cancer in children.

Artisan Advantage

As a subsidiary of cc-TDI, we are well-positioned to rapidly move new or existing drugs with pediatric disease indications to clinical trials, while de-risking capital investment. We are leading with deep preclinical knowledge from cc-TDI’s drug discovery engine and have an extensive pipeline of drug candidates ready to pursue clinical development. Similarly, we aim to use existing, shelved drugs for new pediatric indications using our extensive research in the pediatric cancer research space. We also have pre-existing relationships with academic and industry partners. And most importantly, we are launching Artisan with a support network of 3000+ families touched by pediatric cancer from around the world.

We welcome everyone to help us make a difference.